HDV RNA assays: Performance characteristics, clinical utility, and challenges

Coinfection with HBV and HDV results in hepatitis D, the most severe form of chronic viral hepatitis, frequently leading to liver decompensation and HCC. Pegylated interferon alpha, the only treatment option for chronic hepatitis D for many years, has limited efficacy. New treatments are in advanced...

Celý popis

Podrobná bibliografia

Vydané v:	Hepatology (Baltimore, Md.) Ročník 81; číslo 2; s. 637 - 650
Hlavní autori:	Wedemeyer, Heiner, Leus, Mitchell, Battersby, Thomas R., Glenn, Jeffrey, Gordien, Emmanuel, Kamili, Saleem, Kapoor, Hema, Kessler, Harald H., Lenz, Oliver, Lütgehetmann, Marc, Mixson-Hayden, Tonya, Simon, Christian O., Thomson, Michael, Westman, Gabriel, Miller, Veronica, Terrault, Norah, Lampertico, Pietro
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Lippincott Williams & Wilkins 01.02.2025
Predmet:	Antiviral Agents - therapeutic use Coinfection Hepatitis D - diagnosis Hepatitis D - drug therapy Hepatitis D - virology Hepatitis D, Chronic - diagnosis Hepatitis D, Chronic - drug therapy Hepatitis D, Chronic - virology Hepatitis Delta Virus - genetics Hepatitis Delta Virus - isolation & purification Humans Reviews RNA, Viral - analysis
ISSN:	0270-9139, 1527-3350, 1527-3350
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!